Patents by Inventor Liqing ZHAO

Liqing ZHAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240084203
    Abstract: A heat recovery apparatus and process for cracked gas are provided. The cracked gas comprises liquid feedstock cracked gas and gaseous feedstock cracked gas, and the apparatus comprises a heat recovery device for liquid feedstock cracked gas, a heat recovery device for gaseous feedstock cracked gas and a heavy component removal unit. The invention solves the problems in the art, i.e., incomplete heat recovery technology for cracked gas, insufficient control of viscosity of quench oil, high capital investment and large footprint of the equipment, as well as unstable operation and high energy consumption.
    Type: Application
    Filed: January 27, 2022
    Publication date: March 14, 2024
    Inventors: Zhenwei WANG, Liqing YANG, Bairen ZHAO, Mingrui ZHAO, Gang LIU
  • Patent number: 11786568
    Abstract: Provided is Lactobacillus kefiri MSR101, having the accession member being CGMCC No. 17506. The strain has acid resistance, bile salt resistance, resistance to phenol, antibiotic resistance, antioxidant activity, cell surface hydrophobicity, adhesion to intestinal epithelial cells, and a cholesterol-lowering function.
    Type: Grant
    Filed: March 18, 2020
    Date of Patent: October 17, 2023
    Assignee: SHENZHEN UNIVERSITY
    Inventors: Liqing Zhao, Muhammad Shahid Riza Rajoka
  • Publication number: 20230022968
    Abstract: The present disclosure provides an innovative method for improving the enzyme activity of an NMN biosynthetic enzyme Nampt, and relates to the technical field of genetic engineering. A mutant protein of the present disclosure is obtained by firstly analyzing a target protein Nampt using two softwares FoldX and DeepDDG, and then predicting multiple key sites influencing the enzyme functions and finally performing the semi-rational design of the enzyme. In the examples of the present disclosure, 10 mutant strains are constructed using the designed primers according to the principle of point mutation, and 8 of the mutants have higher activity than a wild-type strain, in which the NMN yield of the mutant Nampt-V365L is increased by 62%, and the NMN yields of the mutants Nampt-S248A, Nampt-N164L, Nampt-S382M, Nampt-A245T and Nampt-A208G are increased by 34%, 27%, 27%, 22% and 17% respectively.
    Type: Application
    Filed: September 21, 2022
    Publication date: January 26, 2023
    Inventors: Liqing ZHAO, Jiansheng Chen, Zhigang Duan, Haichao Zhang, Beijia Huang
  • Patent number: 11492627
    Abstract: The present disclosure provides an innovative method for improving the enzyme activity of an NMN biosynthetic enzyme Nampt, and relates to the technical field of genetic engineering. A mutant protein of the present disclosure is obtained by firstly analyzing a target protein Nampt using two softwares FoldX and DeepDDG, and then predicting multiple key sites influencing the enzyme functions and finally performing the semi-rational design of the enzyme. In the examples of the present disclosure, 10 mutant strains are constructed using the designed primers according to the principle of point mutation, and 8 of the mutants have higher activity than a wild-type strain, in which the NMN yield of the mutant Nampt-V365L is increased by 62%, and the NMN yields of the mutants Nampt-S248A, Nampt-N164L, Nampt-S382M, Nampt-A245T and Nampt-A208G are increased by 34%, 27%, 27%, 22% and 17% respectively.
    Type: Grant
    Filed: September 29, 2021
    Date of Patent: November 8, 2022
    Assignee: HOBOOMLIFE BIO-TECHNOLOGY (SHENZHEN) CO., LTD.
    Inventors: Liqing Zhao, Jiansheng Chen, Zhigang Duan, Haichao Zhang, Beijia Huang
  • Publication number: 20220348931
    Abstract: The present disclosure provides an innovative method for improving the enzyme activity of an NMN biosynthetic enzyme Nampt, and relates to the technical field of genetic engineering. A mutant protein of the present disclosure is obtained by firstly analyzing a target protein Nampt using two softwares FoldX and DeepDDG, and then predicting multiple key sites influencing the enzyme functions and finally performing the semi-rational design of the enzyme. In the examples of the present disclosure, 10 mutant strains are constructed using the designed primers according to the principle of point mutation, and 8 of the mutants have higher activity than a wild-type strain, in which the NMN yield of the mutant Nampt-V365L is increased by 62%, and the NMN yields of the mutants Nampt-S248A, Nampt-N164L, Nampt-S382M, Nampt-A245T and Nampt-A208G are increased by 34%, 27%, 27%, 22% and 17% respectively.
    Type: Application
    Filed: September 29, 2021
    Publication date: November 3, 2022
    Inventors: Liqing Zhao, Jiansheng Chen, Zhigang Duan, Haichao Zhang, Beijia Huang
  • Publication number: 20220282293
    Abstract: The present disclosure provides an Enterobacter chengduensis for producing NMN and application thereof, and relates to the technical field of screening and application of strains. The Enterobacter chengduensis of the present disclosure is determined as a Gram-negative bacterium and belongs to the genus Enterobacter chengduensis. When the Enterobacter chengduensis is used for producing the NMN by fermentation with the nicotinamide as a substrate, the yield of the NMN can reach 67.66 ?M, namely 22.6 mg/L, at 15 minutes, indicating that the wild strain has a strong activity to synthesize the NMN, the dependence on Nampt during synthesis of the NMN is reduced, and a high large-scale application prospect is achieved.
    Type: Application
    Filed: November 7, 2021
    Publication date: September 8, 2022
    Inventors: Liqing Zhao, Jiansheng Chen, Zhigang Duan, Haichao Zhang
  • Publication number: 20220056401
    Abstract: Provided is Lactobacillus kefiri MSR101, having the accession member being CGMCC No. 17506. The strain has acid resistance, bile salt resistance, resistance to phenol, antibiotic resistance, antioxidant activity, cell surface hydrophobicity, adhesion to intestinal epithelial cells, and a cholesterol-lowering function.
    Type: Application
    Filed: March 18, 2020
    Publication date: February 24, 2022
    Inventors: Liqing ZHAO, Muhammad Shahid Riza RAJOKA